![Edward E. Koval](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Edward E. Koval
No open positions remaining
Profile
Edward E.
Koval formerly worked at Veloxis Pharmaceuticals A, as Vice President-Business & Strategic Corporate Deve from 2010 to 2012, X-Chem, Inc. (Massachusetts), as Senior Vice President-Corporate Development from 2013 to 2020, Zebiai Therapeutics, Inc., as Chief Business Officer, and Geron Corp., as Chief Business Officer & Executive Vice President.
Mr. Koval received his undergraduate degree from New York University, graduate degree from Rensselaer Polytechnic Institute, and Masters Business Admin degree from MIT Sloan School of Management.
Former positions of Edward E. Koval
| Companies | Position | End |
|---|---|---|
X-Chem, Inc. (Massachusetts)
 X-Chem, Inc. (Massachusetts) Packaged SoftwareTechnology Services Provides DNA-encoded library-based drug discovery technology services | Corporate Officer/Principal | 2019-12-31 |
| GERON CORPORATION | Corporate Officer/Principal | - |
Zebiai Therapeutics, Inc.
 Zebiai Therapeutics, Inc. Packaged SoftwareTechnology Services Develops artificial intelligence to predict and optimize novel small molecule modulators for challenging drug targets | Corporate Officer/Principal | - |
| VELOXIS PHARMACEUTICALS A/S | Corporate Officer/Principal | - |
Training of Edward E. Koval
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
2
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Geron Corp.
 Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for the prevention of organ rejection in kidney transplant patients | Health Technology |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rensselaer Polytechnic Institute
 Rensselaer Polytechnic Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
X-Chem, Inc. (Massachusetts)
X-Chem, Inc. (Massachusetts) Packaged SoftwareTechnology Services Provides DNA-encoded library-based drug discovery technology services | Technology Services |
MIT Sloan School of Management
 MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zebiai Therapeutics, Inc.
Zebiai Therapeutics, Inc. Packaged SoftwareTechnology Services Develops artificial intelligence to predict and optimize novel small molecule modulators for challenging drug targets | Technology Services |
- Stock Market
- Insiders
- Edward E. Koval
